Table 1.
Overall survival | ||||
---|---|---|---|---|
n | HR (95% CI) | p-value | ||
Age | <60 | 62 | 1 | |
60-70 | 104 | 2.28 [0.99-5.27] | 0.054 | |
>70 | 152 | 2.09 [1.41-3.09] | <0.001 | |
Gender | Female | 141 | 1 | |
Male | 177 | 1.21 [0.80-1.83] | 0.357 | |
UICC stage | Stage I | 64 | 1 | |
Stage II | 128 | 2.15 [1.03-4.47] | 0.041 | |
Stage III | 97 | 1.67 [1.16-2.42] | 0.006 | |
Stage IV | 29 | 1.81 [1.30-2.37] | <0.001 | |
Grade score* | G1 | 93 | 1 | |
G2 | 193 | 1.09 [0.69-1.71] | 0.723 | |
G3-4 | 28 | 1.14 [0.78-1.67] | 0.504 | |
Tumor localisation ** | Colon | 219 | 1 | |
Rectal | 88 | 1.39 [0.91-2.13] | 0.127 |
*Grade score, missing samples: n = 4; Tumor localisation, missing samples: n = 11
Hazard ratios (HR) and 95% confidence intervals (95% CI) were obtained from univariate Cox regression analysis